Eptifibatide

Platelet Aggregation Inhibitor

NADAC/unit N/A

No Shortage 8 Manufacturers 14 ANDAs

Covered Lives

Market Intelligence

2026-03-04 Class III Recall: Slate Run Pharmaceuticals

2024-06-26 Class III Recall: Eugia US LLC

Generic Manufacturers

BAXTER HEALTHCARE CORPEUGIA PHARMA SPECIALITIES LTDHAINAN SHUANGCHENG PHARMACEUTICALS CO LTDMEITHEAL PHARMACEUTICALS INCMYLAN LABORATORIES LTDSAGENT PHARMACEUTICALS INCSLATE RUN PHARMACEUTICALS LLCTEVA PHARMACEUTICALS USA

Explore in the Ecosystem

rxsaver.aiCompare prices for Eptifibatide drfinder.aiFind doctors who prescribe Eptifibatide rxnews.aiLatest news about Eptifibatide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.